1. Indonesia Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
PT Tempo Scan Pacific Tbk

PT Tempo Scan Pacific Tbk

IIDX:TSPC
2,530.00
IDR
+130.00
(+5.42%)
306.30EPS
8.36P/E
11.18TMarket Cap
PT Tempo Scan Pacific Tbk
IDX:TSPC
(Indonesia Stock Exchange)

Recent

price

2,530.00

P/E

ratio

8.36

div

yld

3.57%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
IDR
1,140.94
1,284.59
1,473.51
1,523.31
1,669.36
1,818.11
2,030.72
2,125.66
2,241.8
2,443.08
2,436.48
2,495.73
2,716.05
2,908.25
3,027.59
3,106.11
3,171.75
Revenue per Share
108.64
125.79
139.54
141.03
129.08
115.99
119.17
120.85
113.78
123.17
175
183
222
261
321
312
296.71
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-56.47
-87.47
- -
Free Cash Flow per Basic Share
65
38.02
57.96
57.95
58
49.7
39.13
39.35
31.84
32.09
40.76
65.63
64.65
128.16
88.04
179.97
90.26
Dividend per Share
578.69
668.15
738.28
843.29
897.01
953.03
1,018.27
1,065.96
1,141.53
1,219.23
1,345.82
1,448.02
1,599.87
1,706.91
1,926.84
2,038.18
2,159.21
Book Value per Share
578.69
663
738.28
843.29
897.01
953.03
1,018.27
1,065.96
1,141.53
1,219.23
1,345.82
1,448.02
1,599.87
1,706.91
1,926.84
2,038.18
2,159.21
Tangible Book Value per Share
4,500
4,500
4,500
4,500
4,500
4,500
4,500
4,500
4,500
4,500
4,502
4,501
4,512
4,511
4,510
4,509
4,510
Basic Weighted Avg Shares
5,134,242
5,780,664
6,630,810
6,854,889
7,512,115
8,181,482
9,138,239
9,565,462
10,088,119
10,993,842
10,968,402
11,234,443
12,254,369
13,119,785
13,654,571
14,005,028
14,304,566
Sales/Revenue/Turnover
10.9
11.47
11.22
11.08
9
8.49
7.59
6.65
6.99
7.29
9.84
9.87
5.99
8.27
13.27
12.16
10.85
Operating Margin (%)
- -
- -
76,795
74,529
88,971
116,328
125,308
122,000
128,989
137,707
178,400
189,721
191,698
189,524
305,148
196,829
204,492
Depreciation Expense
488,889
566,048
627,950
634,623
580,870
521,959
536,274
543,804
512,029
554,263
787,803
823,768
1,001,628
1,177,432
1,447,725
1,406,764
1,338,171
Net Income, GAAP
21.4
20.77
21.81
23.06
20.66
25.16
24.13
25.1
25.74
25.25
21.61
20.08
21.98
22.01
20
18.71
16.65
Effective Tax Rate (%)
9.52
9.79
9.47
9.26
7.73
6.38
5.87
5.69
5.08
5.04
7.18
7.33
8.17
8.97
10.6
10.04
9.35
Profit Margin (%)
1,838,960
2,075,573
2,296,644
2,643,650
2,477,369
2,608,435
2,731,671
3,046,742
3,091,587
3,479,030
3,933,073
4,343,725
4,590,003
4,774,667
5,940,682
6,170,678
6,581,170
Working Capital
3,635
2,398
2,119
1,772
4,965
4,081
20,134
15,155
- -
206,320
338,835
473,235
372,008
70,732
59,019
62,232
62,136
LT Debt
2,644,733
3,045,936
3,353,156
3,835,547
4,082,128
4,337,141
4,635,273
5,082,008
5,432,848
5,791,036
6,377,236
6,875,304
7,550,757
8,065,637
9,150,827
9,660,126
10,217,104
Total Equity
16.48
17.41
17.23
15.42
12.92
11.9
11.22
9.23
9.19
9.62
12.31
11.67
6.68
9.12
14.84
13.12
11.45
Return on Invested Capital (%)
18.31
18.57
18.87
17.03
14.24
12.07
11.53
10.75
8.99
8.96
11.54
10.84
12.09
12.82
14.64
13.38
12.14
Return on Capital (%)
19.5
20.18
19.84
17.83
14.83
12.54
12.09
11.6
10.31
10.43
13.65
13.09
14.57
15.79
17.67
15.73
14.21
Return on Common Equity (%)

Capital Structure

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
998,587
1,058,820
1,152,397
LT Borrowings
- -
- -
- -
LT Finance Leases
62,232
63,581
62,136
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4,510
4,510
4,510
Market Capitalization
12,853,113
10,913,872
11,184,463

Working Capital

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
9,045,025
9,268,094
10,029,082
Cash, Cash Equivalents & STI
4,731,142
4,967,034
5,496,799
Accounts Receivable, Net
1,423,968
1,348,387
1,438,217
Inventories
2,257,338
2,225,784
2,457,474
Total Current Liabilities
2,874,347
2,786,399
3,447,912
Payables & Accruals
- -
- -
- -
ST Debt
998,587
1,058,820
1,152,397
Deferred Revenue
- -
- -
- -

Growth Rates

IDR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.36%
8.69%
5.57%
Free Cash Flow
- -
- -
54.84%
Net Income, GAAP
11.25%
12.77%
-2.83%
Sales/Revenue/Turnover
5.58%
5.04%
2.57%
Total Cash Common Dividend
21.91%
46.2%
104.37%

Quarterly Revenue

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,441,768
3,335,251
3,373,355
3,504,196
13,654,571
2025
3,275,227
3,323,485
- -
3,871,148
14,005,028
2026
3,413,260
3,696,672
- -
- -
- -

Quarterly Earnings Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
90
91.71
58.02
80.94
321
2025
91
64.96
- -
59.97
312
2026
78
93.79
- -
- -
- -

Quarterly Dividends Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
22.23
88.04
2025
- -
- -
- -
90.26
179.97
2026
- -
- -
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
PT Tempo Scan Pacific Tbk (TSPC.JK) is an Indonesia-based company engaged in the pharmaceuticals, consumer products and cosmetics, and distribution services businesses. Founded in 1953 with commercial operations starting in 1970, the company, headquartered at Tempo Scan Tower in Jakarta, operates through segments including Pharmaceuticals, which manufactures and trades pharmaceutical products and medical devices such as Bodrex, Bodrexin, Hemaviton, Oskadon, Contrex and Contrexin; Consumer Products and Cosmetics, which produces and markets soaps, herbal products, powder milk, food and beverages, plastic packaging, personal care items like Marina and My Baby brands, baby care, oral hygiene, household care, premium cosmetics including Ultima II, and licensed international brands such as Estee Lauder, Clinique, MAC, Bobbi Brown, La Mer and Revlon; and Distribution Services, which handles procurement, marketing, warehousing, advertising, research and development, and information technology services. It maintains extensive operations across Indonesia through modern and traditional trade channels, with international expansion to Thailand since 2007, the Philippines since 2010, and Malaysia since 2012, functioning as a subsidiary of PT Bogamulia Nagadi. Recent developments include the inauguration of a formula milk and growth milk raw material production facility by PT Kian Mulia Manunggal in Cikarang, expansion of production capacities at factories in Ngoro Industrial Estate and East Jakarta Industrial Park, receipt of the Best Investortrust Awards 2025 and Indonesia Most Excellent Company (IMECO) Awards 2025 for corporate reputation and employee health initiatives, and a credit facility of IDR 1.75 trillion from PT Bank OCBC NISP Tbk in 2022.